TR200003083T2 - CNS hastalıklarının tedavisi için paroxetine 10-camphorsulfonate. - Google Patents
CNS hastalıklarının tedavisi için paroxetine 10-camphorsulfonate.Info
- Publication number
- TR200003083T2 TR200003083T2 TR2000/03083T TR200003083T TR200003083T2 TR 200003083 T2 TR200003083 T2 TR 200003083T2 TR 2000/03083 T TR2000/03083 T TR 2000/03083T TR 200003083 T TR200003083 T TR 200003083T TR 200003083 T2 TR200003083 T2 TR 200003083T2
- Authority
- TR
- Turkey
- Prior art keywords
- paroxetine
- treatment
- camphorsulfonate
- cns diseases
- cns
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
- C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D211/20—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms
- C07D211/22—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms by oxygen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/14—Drugs for dermatological disorders for baldness or alopecia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/32—Alcohol-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
- C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
- C07D317/44—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D317/46—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with one six-membered ring
- C07D317/48—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring
- C07D317/62—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to atoms of the carbocyclic ring
- C07D317/64—Oxygen atoms
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Pain & Pain Management (AREA)
- Psychiatry (AREA)
- Addiction (AREA)
- Child & Adolescent Psychology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Hospice & Palliative Care (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Nutrition Science (AREA)
- Dermatology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB9808894.1A GB9808894D0 (en) | 1998-04-25 | 1998-04-25 | Novel compound |
Publications (1)
Publication Number | Publication Date |
---|---|
TR200003083T2 true TR200003083T2 (tr) | 2001-02-21 |
Family
ID=10831007
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
TR2000/03083T TR200003083T2 (tr) | 1998-04-25 | 1999-04-23 | CNS hastalıklarının tedavisi için paroxetine 10-camphorsulfonate. |
Country Status (18)
Country | Link |
---|---|
EP (1) | EP1076659A1 (pt) |
JP (1) | JP2002513020A (pt) |
KR (1) | KR20010042929A (pt) |
CN (1) | CN1306530A (pt) |
AP (1) | AP2000001958A0 (pt) |
AU (1) | AU3618699A (pt) |
BG (1) | BG104973A (pt) |
BR (1) | BR9909878A (pt) |
CA (1) | CA2329913A1 (pt) |
EA (1) | EA200001105A1 (pt) |
GB (1) | GB9808894D0 (pt) |
HU (1) | HUP0102298A2 (pt) |
IL (1) | IL139018A0 (pt) |
NO (1) | NO20005351L (pt) |
PL (1) | PL343596A1 (pt) |
SK (1) | SK15902000A3 (pt) |
TR (1) | TR200003083T2 (pt) |
WO (1) | WO1999055699A1 (pt) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR100672184B1 (ko) | 2004-09-21 | 2007-01-19 | 주식회사종근당 | 파록세틴의 콜린산 또는 콜린산 유도체 염 |
CN104402708A (zh) * | 2014-12-07 | 2015-03-11 | 河南领先科技药业有限公司 | 一种樟脑酸钠的生产方法 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB8430581D0 (en) * | 1984-12-04 | 1985-01-09 | Ferrosan As | Treatment |
ES2058061T3 (es) * | 1985-10-25 | 1994-11-01 | Beecham Group Plc | Derivado de piperidina, su preparacion y su uso como medicamento. |
HU221921B1 (hu) * | 1996-07-08 | 2003-02-28 | Richter Gedeon Vegyészeti Gyár Rt. | N-benzil-piperidin- és tetrahidropiridinszármazékok és eljárás azok előállítására |
-
1998
- 1998-04-25 GB GBGB9808894.1A patent/GB9808894D0/en not_active Ceased
-
1999
- 1999-04-23 CN CN99807798A patent/CN1306530A/zh active Pending
- 1999-04-23 EA EA200001105A patent/EA200001105A1/ru unknown
- 1999-04-23 SK SK1590-2000A patent/SK15902000A3/sk unknown
- 1999-04-23 PL PL99343596A patent/PL343596A1/xx not_active Application Discontinuation
- 1999-04-23 IL IL13901899A patent/IL139018A0/xx unknown
- 1999-04-23 BR BR9909878-4A patent/BR9909878A/pt not_active Application Discontinuation
- 1999-04-23 AP APAP/P/2000/001958A patent/AP2000001958A0/en unknown
- 1999-04-23 CA CA002329913A patent/CA2329913A1/en not_active Abandoned
- 1999-04-23 HU HU0102298A patent/HUP0102298A2/hu unknown
- 1999-04-23 JP JP2000545859A patent/JP2002513020A/ja active Pending
- 1999-04-23 WO PCT/GB1999/001246 patent/WO1999055699A1/en not_active Application Discontinuation
- 1999-04-23 EP EP99918153A patent/EP1076659A1/en not_active Withdrawn
- 1999-04-23 AU AU36186/99A patent/AU3618699A/en not_active Abandoned
- 1999-04-23 TR TR2000/03083T patent/TR200003083T2/xx unknown
- 1999-04-23 KR KR1020007011750A patent/KR20010042929A/ko not_active Application Discontinuation
-
2000
- 2000-10-24 NO NO20005351A patent/NO20005351L/no not_active Application Discontinuation
- 2000-11-21 BG BG104973A patent/BG104973A/bg unknown
Also Published As
Publication number | Publication date |
---|---|
AP2000001958A0 (en) | 2000-12-31 |
EA200001105A1 (ru) | 2001-04-23 |
BG104973A (bg) | 2001-09-28 |
PL343596A1 (en) | 2001-08-27 |
JP2002513020A (ja) | 2002-05-08 |
BR9909878A (pt) | 2000-12-26 |
NO20005351D0 (no) | 2000-10-24 |
CN1306530A (zh) | 2001-08-01 |
SK15902000A3 (sk) | 2001-05-10 |
NO20005351L (no) | 2000-10-24 |
KR20010042929A (ko) | 2001-05-25 |
HUP0102298A2 (hu) | 2002-05-29 |
AU3618699A (en) | 1999-11-16 |
GB9808894D0 (en) | 1998-06-24 |
WO1999055699A1 (en) | 1999-11-04 |
CA2329913A1 (en) | 1999-11-04 |
EP1076659A1 (en) | 2001-02-21 |
IL139018A0 (en) | 2001-11-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PT1140944E (pt) | Derivados de epotilona e sua utilizacao como agentes antitumorais | |
DE60010098D1 (de) | 28-epirapaloge | |
NO20013444D0 (no) | Triazolforbindelser med dopamin-D3-reseptor-affinet | |
DK1187632T3 (da) | Behandling med anti-ErbB2-antistoffer | |
DE60218493D1 (de) | Substituierte 7-aza-ä2.2.1übicycloheptane für die behandlung von krankheiten | |
CR6540A (es) | Trifluorobutenos nematicidas | |
DK1083903T3 (da) | Brobundne indenopyrrolocarbazoler | |
IT1298535B1 (it) | Procedimento per la produzione di gamma-butirrolattone | |
PT1060175E (pt) | Inibidores de triptase | |
ID27214A (id) | Triazolopiridina untuk pengobatan gangguan trombosis | |
IT1298096B1 (it) | Procedimento per la produzione di gamma-butirrolattone | |
BR0012921A (pt) | Compostos calcilìticos | |
ATE230741T1 (de) | 3-tetrahydropyridin-4-yl-indole zur behandlung von psychotischen störungen | |
NO20005548D0 (no) | Mykobakterieinhibitorer | |
TR200003083T2 (tr) | CNS hastalıklarının tedavisi için paroxetine 10-camphorsulfonate. | |
NO990450D0 (no) | Behandling av sinnslidelser | |
DE60005685D1 (de) | Oxazinocarbazole zur behandlung von cns-erkrankungen | |
TR200003084T2 (tr) | Paroxetine askorbat | |
ID27656A (id) | Turunan azabisikloheptana n-tersubstitusi, pembuatan dan penggunaannya | |
DE69927796D1 (de) | Verbesserung des Herstellungsverfahrens von Schuhwerk | |
DE69721699D1 (de) | Enrichtung zum herstellen von zigaretten | |
NO20006383L (no) | Fremgangsmåte for behandling | |
PE61999A1 (es) | Compuestos de tetrahidropiridina | |
NO996166D0 (no) | Fremgangsmåte for behandling av avluter | |
IT1305242B1 (it) | Preparatore di mazzi di pelli. |